Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-009450

Chief Executive Officer acquired 2,128 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Townsend Richard Nolan Chief Executive Officer 2025-03-14 Grant or award +2,128 $2.61 $5,554 222,247 D
Loading xslF345X05/form4-04012025_110414.xml…